Y
Live / Applied — Fourth extension granted (statement of use) (as of 12 Aug 2025)
What this means for you
Not registered yet, but its 16 Nov 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97126771
- Mark type
- Design + words
- Filed
- 16 Nov 2021
- Published for opposition
- 20 Jun 2023
- Attorney of record
- John P. Rynkiewicz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals preparations containing biological or chemical therapeutics for use in oncology and immunology and for the treatment of infectious and metabolic diseases; medical preparations for the treatment ofneurological, oncological and immunological diseases and disorders, and dietary supplements for human beings and animals, medical plasters and fungicides for use in oncology and immunology and for the treatment of infectious and metabolic diseases; veterinary pharmaceutical preparations containing biological or chemical therapeutics for use in oncology and immunology and for the treatment of infectious and metabolic diseases; sanitary preparations for medical purposes
- Class 010 — Medical apparatus: Surgical apparatus and instruments for treating various conditions related to oncology, immunology, infectious and metabolic diseases
- Class 035 — Advertising and business services: Retail and wholesale store services in the field of pharmaceutical, veterinary and sanitary preparations and medical supplies; personnel management consulting; business management and organization consultancy; retail and wholesale services by direct solicitation by sales agents in the field of oncology, immunology, infectious and metabolic diseases; import export agency services; marketing services
- Class 041 — Education and entertainment services: Business training; educational services, namely, conducting classes, seminars, conferences and webinars in the fields of oncology, immunology, infectious and metabolic diseases
- Class 042 — Scientific and technological services: Implementation of early assessment in new drug development fields to develop pharmaceutical preparations and medicines; scientific research and development; product quality testing; drug evaluation, in the nature of product quality evaluation, namely, drug discovery evaluation, drug developablity, drug efficacy, and drug metabolic kinetics for various biological or chemical therapeutics for oncology, immunology, infectious and metabolic diseases; pharmaceutical research services; biological research and analysis; technical research in the field of oncology, immunology, infectious and metabolic diseases; chemical research and analysis; bacteriological research and analysis; scientific research in the nature of conducting clinical trials for others; product research and development; scientific laboratory services
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of pharmaceutical products, medicines, vaccines, healthcare, health issues, health awareness and treatment options; On-line information services, namely, providing health information to physicians, healthcare professionals and patients on the topics of health issues, pharmaceutical products and treatments; Providing medical information via a website; providing a website featuring medical information for oncology, immunology, infectious and metabolic diseases
Owner
- TopAlliance Biosciences Inc., Menlo Park, CA, US
- TopAlliance Biosciences Inc., Menlo Park, CA, US
Prosecution history
- 12 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 13 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2025 — SOU EXTENSION 4 GRANTED
- 12 Aug 2025 — SOU EXTENSION 4 FILED
- 12 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 3 GRANTED
- 12 Feb 2025 — SOU EXTENSION 3 FILED
- 12 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Aug 2024 — SOU EXTENSION 2 GRANTED
- 15 Aug 2024 — SOU EXTENSION 2 FILED
- 15 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED